Market Overview

Trade GMED stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
4/16/18BTIG ResearchDowngradesBuyNeutral0.0
4/04/18NeedhamUpgradesHoldBuy0.0
3/28/18Leerink SwannMaintainsOutperformOutperform60.0

Earnings View Earnings

Q4 2017 EST Actual Surprise
EPS: 0.35 0.38 0.03
Rev: 166.53M 176.03M 9.50M
Q1 2018 EST Actual Surprise
EPS: 0.36 Expected
2018-05-02
Rev: 167.95M

Company Profile